Unknown

Dataset Information

0

Targeted viral vector transduction of relaxin-3 neurons in the rat nucleus incertus using a novel cell-type specific promoter.


ABSTRACT: Modern neuroscience utilizes transgenic techniques extensively to study the activity and function of brain neural networks. A key feature of this approach is its compatibility with molecular methods for selective transgene expression in neuronal circuits of interest. Until now, such targeted transgenic approaches have not been applied to the extensive circuitry involving the neuropeptide, relaxin-3. Pharmacological and gene knock-out studies have revealed relaxin-3 signalling modulates interrelated behaviours and cognitive processes, including stress and anxiety, food and alcohol consumption, and spatial and social memory, highlighting the potential of this system as a therapeutic target. In the present study, we aimed to identify a promoter sequence capable of regulating cell-type specific transgene expression from an adeno-associated viral (AAV) vector in relaxin-3 neurons of the rat nucleus incertus (NI). In parallel to relaxin-3 promoter sequences, we also tested an AAV vector containing promoter elements for the tropomyosin receptor kinase A (TrkA) gene, as TrkA is co-expressed with relaxin-3 in rat NI neurons. Stereotaxic injection of an mCherry-expressing AAV vector revealed widespread non-specific TrkA promoter (880 bp) activity in and adjacent to the NI at 8 weeks post-treatment. In contrast, mCherry expression was successfully restricted to relaxin-3 NI neurons with 98% specificity using a 1736 bp relaxin-3 promoter. In addition to detailed anatomical mapping of NI relaxin-3 networks, illustrated here in association with GABAergic medial septum neurons, this method for targeted transgene delivery offers a versatile tool for ongoing preclinical studies of relaxin-3 circuitry.

SUBMITTER: Wykes AD 

PROVIDER: S-EPMC6928288 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeted viral vector transduction of relaxin-3 neurons in the rat <i>nucleus incertus</i> using a novel cell-type specific promoter.

Wykes Alexander D AD   Ma Sherie S   Bathgate Ross A D RAD   Gundlach Andrew L AL  

IBRO reports 20191213


Modern neuroscience utilizes transgenic techniques extensively to study the activity and function of brain neural networks. A key feature of this approach is its compatibility with molecular methods for selective transgene expression in neuronal circuits of interest. Until now, such targeted transgenic approaches have not been applied to the extensive circuitry involving the neuropeptide, relaxin-3. Pharmacological and gene knock-out studies have revealed relaxin-3 signalling modulates interrela  ...[more]

Similar Datasets

| S-EPMC3410922 | biostudies-literature
| S-EPMC8258164 | biostudies-literature
| S-EPMC7210779 | biostudies-literature
| S-EPMC6403382 | biostudies-literature
| S-EPMC3500400 | biostudies-literature
| S-EPMC5081123 | biostudies-literature
| S-EPMC10250478 | biostudies-literature
| S-EPMC11303397 | biostudies-literature
| S-EPMC6729167 | biostudies-literature
| S-EPMC6959274 | biostudies-literature